427 related articles for article (PubMed ID: 23418957)
1. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
Golubnitschaja O; Yeghiazaryan K; Costigliola V; Trog D; Braun M; Debald M; Kuhn W; Schild HH
EPMA J; 2013 Feb; 4(1):6. PubMed ID: 23418957
[TBL] [Abstract][Full Text] [Related]
2. 'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention.
Debald M; Yeghiazaryan K; Cebioglu M; Kuhn W; Schild HH; Golubnitschaja O
EPMA J; 2013 Sep; 4(1):22. PubMed ID: 24228816
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.
Golubnitschaja O; Debald M; Yeghiazaryan K; Kuhn W; Pešta M; Costigliola V; Grech G
Tumour Biol; 2016 Oct; 37(10):12941-12957. PubMed ID: 27448308
[TBL] [Abstract][Full Text] [Related]
4. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
5. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within 'Horizon 2020'.
Lemke HU; Golubnitschaja O
EPMA J; 2014; 5(1):8. PubMed ID: 24883142
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper.
Golubnitschaja O; Kinkorova J; Costigliola V
EPMA J; 2014 Apr; 5(1):6. PubMed ID: 24708704
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.
Polivka J; Altun I; Golubnitschaja O
EPMA J; 2018 Mar; 9(1):1-13. PubMed ID: 29515683
[TBL] [Abstract][Full Text] [Related]
9. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?
Polivka J; Kralickova M; Polivka J; Kaiser C; Kuhn W; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):119-127. PubMed ID: 28824737
[TBL] [Abstract][Full Text] [Related]
10. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine.
Golubnitschaja O; Filep N; Yeghiazaryan K; Blom HJ; Hofmann-Apitius M; Kuhn W
Amino Acids; 2018 Apr; 50(3-4):383-395. PubMed ID: 29249020
[TBL] [Abstract][Full Text] [Related]
11. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine.
Golubnitschaja O; Costigliola V;
EPMA J; 2012 Nov; 3(1):14. PubMed ID: 23116135
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal breast cancer: European challenge and innovative concepts.
Smokovski I; Risteski M; Polivka J; Zubor P; Konieczka K; Costigliola V; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):159-169. PubMed ID: 28824739
[TBL] [Abstract][Full Text] [Related]
13. Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.
Mazurakova A; Koklesova L; Vybohova D; Samec M; Kudela E; Biringer K; Šudomová M; Hassan STS; Kello M; Büsselberg D; Golubnitschaja O; Kubatka P
Front Pharmacol; 2023; 14():1160068. PubMed ID: 37089930
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
15. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
16. The role of human-at-work systems in business sustainability: perspectives based on expert and qualified production workers in a manufacturing enterprise.
Genaidy AM; Rinder MM; Sequeira R; A-Rehim A
Ergonomics; 2010 Apr; 53(4):559-85. PubMed ID: 20309751
[TBL] [Abstract][Full Text] [Related]
17. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
Morigi C
Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
[TBL] [Abstract][Full Text] [Related]
18. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
